Ultrasound Fusion Biopsy Market Strategies for Expansion Analysis Report: Opportunities and Challenges Ahead

The global market for Ultrasound Fusion Biopsy was estimated to be worth US$ 523 million in 2024 and is forecast to a readjusted size of US$ 757 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031. Ultrasound Fusion Biopsy is a medical technique that combines ultrasound imaging with MRI (Magnetic Resonance Imaging) or CT (Computed Tomography) scans to guide a biopsy procedure. It is primarily used in the diagnosis of prostate cancer but has applications in other areas of oncology as well. The term "fusion" refers to the process of integrating images from two different sources (ultrasound and MRI/CT) to provide a more accurate and detailed map for the biopsy procedure.